Economics of the Pharmaceutical Industry
From PHM Oz
(Difference between revisions)
| Line 1: | Line 1: | ||
<center>''This page is under construction, please be patient as we develop it further''</center> | <center>''This page is under construction, please be patient as we develop it further''</center> | ||
| + | guaranteed profits justified in terms of generating funds for drug development | ||
| + | but relatively low proportion of revenues going to research | ||
| + | Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs | ||
| + | investment in drug development | ||
| + | |||
| + | Research often funded by public purse (universities) but profits go to industry. | ||
[[Intellectual Property and Pharmaceuticals|Back to IP home]] | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | ||
Revision as of 04:06, 16 June 2007
guaranteed profits justified in terms of generating funds for drug development but relatively low proportion of revenues going to research
Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs investment in drug development
Research often funded by public purse (universities) but profits go to industry.
